Dumusc, A., Alromaih, F., Perreau, M., Hügle, T., Zufferey, P., & Dan, D. (2023). Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: A single-centre Swiss retrospective cohort study. BMC.
Chicago Style (17th ed.) CitationDumusc, Alexandre, Fahad Alromaih, Matthieu Perreau, Thomas Hügle, Pascal Zufferey, and Diana Dan. Real-life Drug Retention Rate and Safety of Rituximab When Treating Rheumatic Diseases: A Single-centre Swiss Retrospective Cohort Study. BMC, 2023.
MLA (9th ed.) CitationDumusc, Alexandre, et al. Real-life Drug Retention Rate and Safety of Rituximab When Treating Rheumatic Diseases: A Single-centre Swiss Retrospective Cohort Study. BMC, 2023.
Warning: These citations may not always be 100% accurate.